Published in Epilepsy Curr on January 01, 2011
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia (2010) 18.28
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (2009) 7.03
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia (2010) 5.64
Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia (2007) 4.33
The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89
Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia (2008) 2.87
Practice parameters and technology assessments: what they are, what they are not, and why you should care. Neurology (2008) 2.83
Detrimental effects of the ketogenic diet on cognitive function in rats. Pediatr Res (2004) 2.60
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology (2012) 2.36
The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia (2007) 2.20
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia (2014) 1.97
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol (2009) 1.73
Disparities in NIH funding for epilepsy research. Neurology (2011) 1.69
Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia (2003) 1.66
Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol (2006) 1.65
Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol (2005) 1.60
Cognitive development in children with new onset epilepsy. Dev Med Child Neurol (2014) 1.55
The neuropharmacology of the ketogenic diet. Pediatr Neurol (2007) 1.54
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J Neurosci (2002) 1.49
Glia and epilepsy: excitability and inflammation. Trends Neurosci (2013) 1.49
Is lower IQ in children with epilepsy due to lower parental IQ? A controlled comparison study. Dev Med Child Neurol (2012) 1.46
Neurodevelopment in new-onset juvenile myoclonic epilepsy over the first 2 years. Ann Neurol (2014) 1.45
Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci (2003) 1.45
Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol (2007) 1.44
Longitudinal trajectories of behavior problems and social competence in children with new onset epilepsy. Dev Med Child Neurol (2014) 1.43
It's time to eliminate the term seizure disorder from our lexicon. Epilepsia (2005) 1.37
Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics (2011) 1.36
Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia (2004) 1.36
The epilepsy phenome/genome project. Clin Trials (2013) 1.32
Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia (2005) 1.30
Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia (2004) 1.25
Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol (2006) 1.23
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology (2004) 1.21
Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology (2005) 1.20
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet (2012) 1.15
Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia (2011) 1.14
The neuropsychological and academic substrate of new/recent-onset epilepsies. J Pediatr (2012) 1.12
How theories evolved concerning the mechanism of action of barbiturates. Epilepsia (2012) 1.10
Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics (2009) 1.09
How does the ketogenic diet work? Four potential mechanisms. J Child Neurol (2013) 1.08
Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res (2010) 1.07
Pregnancy registries: differences, similarities, and possible harmonization. Epilepsia (2010) 1.06
Who is helping whom? Manuscript support and transfer of value. Ann Neurol (2015) 1.06
Detection of epileptogenic cortical malformations with surface-based MRI morphometry. PLoS One (2011) 1.05
Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus. Epilepsy Res (2002) 1.04
Striatal hypertrophy and its cognitive effects in new-onset benign epilepsy with centrotemporal spikes. Epilepsia (2012) 1.03
New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res (2002) 1.01
Origins of epilepsy in fragile X syndrome. Epilepsy Curr (2009) 1.00
Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol (2004) 1.00
Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study. Epilepsia (2014) 0.98
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol (2011) 0.97
Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia (2007) 0.96
Default mode network abnormalities in idiopathic generalized epilepsy. Epilepsy Behav (2012) 0.96
Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging (2011) 0.96
Issues related to development of new antiseizure treatments. Epilepsia (2013) 0.96
Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicol Sci (2012) 0.95
Therapeutic potential of new antiinflammatory drugs. Epilepsia (2011) 0.95
Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res (2006) 0.94
Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther (2012) 0.94
Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia (2010) 0.94
Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia (2009) 0.93
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics (2014) 0.93
Nontraditional epilepsy treatment approaches. Neurotherapeutics (2009) 0.92
Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome. Neurology (2012) 0.91
Perampanel for adjunctive treatment of partial-onset seizures: a pooled dose-response analysis of phase III studies. Epilepsia (2014) 0.91
Effects of neurosteroids on epileptiform activity induced by picrotoxin and 4-aminopyridine in the rat hippocampal slice. Epilepsy Res (2003) 0.91
Termination of epileptiform activity by cooling in rat hippocampal slice epilepsy models. Epilepsy Res (2006) 0.90
Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J Pharmacol Exp Ther (2009) 0.89
Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia (2009) 0.89
Neonatal hypocalcemic seizures due to excessive maternal calcium ingestion. Pediatr Neurol (2013) 0.89
Ventricular enlargement in new-onset pediatric epilepsies. Epilepsia (2011) 0.88
Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia (2013) 0.88
Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev (2007) 0.88
Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy. Ann Neurol (2003) 0.88
Galloway-Mowat syndrome: neurologic features in two sibling pairs. Pediatr Neurol (2012) 0.86
Neonatal seizures: is a novel, mechanism-based treatment finally on the horizon? Epilepsy Curr (2007) 0.86
Neurodevelopmental alterations of large-scale structural networks in children with new-onset epilepsy. Hum Brain Mapp (2014) 0.86
Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav (2007) 0.85
Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol (2014) 0.85
Volume of the human septal forebrain region is a predictor of source memory accuracy. J Int Neuropsychol Soc (2011) 0.85
Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiol Dis (2012) 0.85
Propofol hemisuccinate suppresses cortical spreading depression. Neurosci Lett (2012) 0.85
Point-counterpoint: Do interictal spikes trigger seizures or protect against them? Epilepsy Curr (2007) 0.85
The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors. J Pharmacol Exp Ther (2006) 0.85
Harnessing the power of metabolism for seizure prevention: focus on dietary treatments. Epilepsy Behav (2012) 0.85
Behavioral, cognitive, and safety profile of 2-deoxy-2-glucose (2DG) in adult rats. Epilepsy Res (2012) 0.84
Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA. J Pharmacol Exp Ther (2007) 0.84
The ketogenic diet: what has science taught us? Epilepsy Res (2011) 0.84
Role of neurosteroids in the anticonvulsant activity of midazolam. Br J Pharmacol (2012) 0.82
Individual differences in verbal abilities associated with regional blurring of the left gray and white matter boundary. J Neurosci (2011) 0.82
Interictal spikes: memories forsaken. Epilepsy Curr (2010) 0.81
11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology (2011) 0.80
Progress toward understanding epileptogenesis in tuberous sclerosis complex: two hits, no outs, and the Eker rat is up to bat. Epilepsy Curr (2005) 0.80
Regulation of brain water: is there a role for aquaporins in epilepsy? Epilepsy Curr (2005) 0.80
Children with epilepsy and anxiety: Subcortical and cortical differences. Epilepsia (2015) 0.79
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant. Neurotherapeutics (2015) 0.79
Septal nuclei enlargement in human temporal lobe epilepsy without mesial temporal sclerosis. Neurology (2013) 0.79
Neurocysticercosis in Wisconsin: 3 cases and a review of the literature. WMJ (2014) 0.79